Holoprosencephaly
Holoprosencephaly is a congenital disorder that affects the development of the brain in the early stages of pregnancy. This condition is characterized by the failure of the prosencephalon (the forebrain of the embryo) to develop. As a result, the brain does not divide into two hemispheres, leading to defects in the structure and function of the brain.
Causes[edit | edit source]
Holoprosencephaly is caused by a combination of genetic and environmental factors. Mutations in certain genes, such as SHH, ZIC2, SIX3, and TGIF1, have been associated with this condition. Environmental factors, such as maternal diabetes, alcohol use during pregnancy, and certain infections, can also increase the risk of holoprosencephaly.
Symptoms[edit | edit source]
The symptoms of holoprosencephaly can vary widely, depending on the severity of the brain malformation. In severe cases, symptoms can include microcephaly (small head size), hydrocephalus (buildup of fluid in the brain), seizures, and intellectual disability. In milder cases, symptoms can include hypotelorism (closely spaced eyes), cleft lip and/or cleft palate, and mild learning disabilities.
Diagnosis[edit | edit source]
Holoprosencephaly can often be diagnosed before birth through ultrasound imaging. After birth, the diagnosis can be confirmed through magnetic resonance imaging (MRI) or computed tomography (CT) scans of the brain.
Treatment[edit | edit source]
There is currently no cure for holoprosencephaly. Treatment is supportive and depends on the symptoms. This can include medications to manage seizures, shunt surgery for hydrocephalus, and therapies to address developmental delays.
Prognosis[edit | edit source]
The prognosis for individuals with holoprosencephaly depends on the severity of the brain malformation. Those with severe forms of the condition often do not survive past infancy. Those with milder forms can live into adulthood, but may have intellectual and physical disabilities.
See also[edit | edit source]
| Holoprosencephaly Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
